The company had already achieved significant success with Tirzepatide, which activates two receptors (GIP and GLP-1)
According to Yale Medicine, injectable GLP-1s have a slight edge in clinical trials
Real-world example: hair loss after weight-loss, supported with targeted haircare Consider a 42-year-old woman who loses 15% of her body weight within six months of starting a GLP-1 injection
In that trial, diarrhoea was reported in approximately 2030% of participants receiving higher doses of retatrutide, with rates varying by dose level and stage of titration
Common sites for transdermal patches include the abdomen (avoiding waistline and navel), outer upper arm, anterior or lateral thigh, and upper back or shoulder area
trial participants must not stop retatrutide without consulting their trial team